Johns Hopkins researchers recommend reclassifying magic mushrooms from schedule I to IV drug

[Mangochin]

Meanwhile Peyote has a problem other than its drug scheduling status, it is becoming endangered.
https://www.npr.org/templates/story/story.php?storyId=14064806